1 |
Ong CW, Kim LG, Kong HH, Low LY, Iacopetta B, Soong R, et al. 2010. CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod. Pathol. 23: 450-457.
DOI
|
2 |
Du L, Wang H, He L, Zhang J, Ni B, Wang X, et al. 2008. CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res. 14: 6751-6760.
DOI
|
3 |
Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69: 3382-3389.
DOI
|
4 |
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
DOI
|
5 |
Moon Y. 2011. Mucosal Injuries due to Ribosome-Inactivating Stress and the Compensatory Responses of the Intestinal Epithelial Barrier. Toxins 3: 1263-1277.
DOI
|
6 |
Maresca M, Fantini J. 2010. Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 56: 282-294.
DOI
|
7 |
Mishra S, Tewari P, Chaudhari BP, Dwivedi PD, Pandey HP, Das M. 2016. Deoxynivalenol induced mouse skin tumor initiation: Elucidation of molecular mechanisms in human HaCaT keratinocytes. Int. J. Cancer. 139: 2033-2046.
DOI
|
8 |
Graziani F, Pujol A, Nicoletti C, Pinton P, Armand L, Di Pasquale E, et al. 2015. The food-associated ribotoxin deoxynivalenol modulates inducible NO synthase in human intestinal cell model. Toxicol. Sci. 145: 372-382.
DOI
|
9 |
Yoder JM, Aslam RU, Mantis NJ. 2007. Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication. Infect. Immun. 75: 1745-1750.
DOI
|
10 |
Islam Z, Gray JS, Pestka JJ. 2006. p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicol. Appl. Pharmacol. 213: 235-244.
DOI
|
11 |
Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, et al. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol. Cell Biol. 17: 3373-3381.
DOI
|
12 |
Shifrin VI, Anderson P. 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem. 274: 13985-13992.
DOI
|
13 |
Park SH, Choi HJ, Yang H, Do KH, Kim J, Moon Y. 2010. Repression of peroxisome proliferator-activated receptor gamma by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein. J. Immunol. 185: 5522-5530.
DOI
|
14 |
Edmondson R, Broglie JJ, Adcock AF, Yang L. 2014. Threedimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 12: 207-218.
DOI
|
15 |
Zhou HR, Lau AS, Pestka JJ. 2003. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenolinduced ribotoxic stress response. Toxicol. Sci. 74: 335-344.
DOI
|
16 |
Laskin JD, Heck DE, Laskin DL. 2002. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol. Sci. 69: 289-291.
DOI
|
17 |
Birgersdotter A, Sandberg R, Ernberg I. 2005. Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems. Semin. Cancer Biol. 15: 405-412.
|
18 |
Kim JB. 2005. Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 15: 365-377.
|
19 |
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. 2006. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 244: 254-259.
DOI
|
20 |
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. 2004. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
DOI
|
21 |
Jin K, Gao W, Lu Y, Lan H, Teng L, Cao F. 2012. Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncol. Lett. 3: 11-15.
DOI
|
22 |
O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunode-ficient mice. Nature 445: 106-110.
DOI
|
23 |
Cho RW, Clarke MF. 2008. Recent advances in cancer stem cells. Curr. Opin. Genet. Dev. 18: 48-53.
DOI
|
24 |
Abdullah LN, Chow EK. 2013. Mechanisms of chemoresistance in cancer stem cells. Clin. Transl. Med. 2: 3.
DOI
|
25 |
Kozovska Z, Gabrisova V, Kucerova L. 2014. Colon cancer: cancer stem cells markers, drug resistance and treatment. Biomed. Pharmacother. 68: 911-916.
DOI
|
26 |
Oh CK, Lee SJ, Park SH, Moon Y. 2016. Acquisition of chemoresistance and other malignancy-related features of colorectal cancer cells are incremented by Ribosome-inactivating stress. J. Biol. Chem. 291: 10173-10183.
DOI
|
27 |
Choi HJ, Kim J, Do KH, Park SH, Moon Y. 2013. Prolonged NF-kappaB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect. Immun. 81: 1860-1869.
DOI
|
28 |
Fluckiger A, Dumont A, Derangere V, Rebe C, de Rosny C, Causse S, et al. 2016. Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNF . Oncogene 35: 4611-4622.
DOI
|
29 |
Howard A, Tahir I, Javed S, Waring SM, Ford D, Hirst BH. 2010. Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage. J. Physiol. 588: 995-1009.
DOI
|